Extracranially, TP53 and somatic copy number variations were associated with lung cancer.5,6 Concordant with previous findings, we first found that patients with CNS metastases characterized by TP53 and somatic copy number variations in CSF had poor survival. This evidence concerns the gene TP53 and lung carcinoma.